These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31082624)

  • 1. An octogenarian with Parkinson's disease psychosis that has responded favourably to low-dose sulpiride with facilitated motoric agility.
    Naguy A; AlHumoud A
    Asian J Psychiatr; 2019 Jun; 43():55-56. PubMed ID: 31082624
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities in using sulpiride in the treatment of psychotic disorders].
    Danilov DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):91-7. PubMed ID: 22983256
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease.
    Wolters EC; Jansen EN; Tuynman-Qua HG; Bergmans PL
    Neurology; 1996 Oct; 47(4):1085-7. PubMed ID: 8857751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pimavanserin (Nuplazid) for Parkinson's disease psychosis.
    Med Lett Drugs Ther; 2016 Jun; 58(1496):74-5. PubMed ID: 27249096
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment with amisulpride for poststroke psychosis.
    Chen JH; Tzeng NS
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352.e1. PubMed ID: 20686144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evidence-based treatment of psychosis associated with Parkinson's disease].
    Haussmann R; Bauer M; Donix M
    Nervenarzt; 2016 May; 87(5):543-51. PubMed ID: 26643499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT
    Huot P
    Neurodegener Dis Manag; 2018 Dec; 8(6):363-365. PubMed ID: 30451579
    [No Abstract]   [Full Text] [Related]  

  • 8. The Efficacy and Safety of Antipsychotic Medications in the Treatment of Psychosis in Patients with Parkinson's Disease.
    Divac N; Stojanović R; Savić Vujović K; Medić B; Damjanović A; Prostran M
    Behav Neurol; 2016; 2016():4938154. PubMed ID: 27504054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of psychosis in movement disorder patients.
    Chou KL; Borek LL; Friedman JH
    Expert Opin Pharmacother; 2007 May; 8(7):935-43. PubMed ID: 17472539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ziprasidone in the treatment of Parkinson's disease psychosis.
    Shiah IS; Lin CL; Mao WC; Luu SU
    Eur Psychiatry; 2006 Dec; 21(8):578-9. PubMed ID: 16139485
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful Use of Brexpiprazole for Parkinson's Disease Psychosis Without Adverse Effects: A Case Report.
    Sanagawa A; Shiraishi N; Sekiguchi F; Akechi T; Kimura K
    J Clin Psychopharmacol; 2019; 39(6):685-687. PubMed ID: 31688389
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].
    Diraoui S; van Melick EJ; Jansen PA
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2365-8. PubMed ID: 15615268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.
    Cummings J; Isaacson S; Mills R; Williams H; Chi-Burris K; Corbett A; Dhall R; Ballard C
    Lancet; 2014 Feb; 383(9916):533-40. PubMed ID: 24183563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of psychosis in Parkinson's disease: safety considerations.
    Fernandez HH; Trieschmann ME; Friedman JH
    Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A successful antipsychotic combination trial. Quo Vadis?
    Stahl S; Freudenreich O; Goff D
    Acta Psychiatr Scand; 2004 Oct; 110(4):241-2. PubMed ID: 15352924
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.
    Broadstock M; Ballard C; Corbett A
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):779-86. PubMed ID: 25301532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
    Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
    Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride-induced mania with interictal psychosis.
    Bakhla AK; Goyal N; Nizamie SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1572-3. PubMed ID: 19766159
    [No Abstract]   [Full Text] [Related]  

  • 19. Melperone is ineffective in treating Parkinson's disease psychosis.
    Friedman JH
    Mov Disord; 2012 May; 27(6):803-4. PubMed ID: 22362330
    [No Abstract]   [Full Text] [Related]  

  • 20. Amisulpride treatment of somatoform disorders: not just chronic fatigue.
    Goswami K; Saddichha S; Chaturvedi SK
    Am J Ther; 2014; 21(2):e48-9. PubMed ID: 23011165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.